Robles BioCeutics Files Landmark Patent on First-In-Class Cosmetic Rejuvenation Product Glowselle
Robles BioCeutics Files Landmark Patent on First-In-Class Cosmetic Rejuvenation Product Glowselle
"This patent filing reflects the passion and effort our team has put into developing something we're very proud of and believe will have a real impact," said Regenerative Dermatology Company Succeeds in Increasing Exosome Quantity and Quality by Toll Like Receptor Manipulation
再生皮膚醫學公司通過調節Toll樣受體成功增加外泌體數量和質量
SAN DIEGO, Sept. 27, 2024 /PRNewswire/ -- Robles BioCeutics, a regenerative dermatology company, announced today the submission of patent application #63/695,813, titled "Activated Stem Cell Derived Products for Stimulation of Skin Regeneration." Filed by Knobbe Martens, one of the nation's leading intellectual property law firms, the application covers both the composition of matter and the production methodologies for a key ingredient in the company's Glowselle regenerative cream.
2024年9月27日，聖地亞哥 / PRNewswire / - 再生皮膚醫學公司Robles BioCeutics 今日宣佈遞交了專利申請＃63/695,813，題爲「激活幹細胞衍生產品用於皮膚再生刺激」。 由美國領先的知識產權法律事務所Knobbe Martens代表，該申請涵蓋了公司Glowselle再生霜中關鍵成分的實質和生產方法。
In contrast to traditional methods that utilize products derived from stem cells in a resting state, Robles BioCeutics has demonstrated that products isolated from "activated" stem cells possess significantly higher regenerative activity. Specifically, the company's approach has shown up to 10 times higher production of therapeutic exosomes and growth factors compared to standard adipose-derived stem cells, which are the industry norm. This breakthrough underscores the company's commitment to advancing the science of skincare through innovative solutions that address the root causes of skin aging.
與利用靜止狀態幹細胞衍生產品的傳統方法相比，Robles BioCeutics已經證明從「激活」幹細胞中分離的產品具有顯着更高的再生活性。 具體地，該公司的方法顯示出比行業標準的脂肪來源幹細胞高達10倍的治療外泌體和生長因子生產。 這一突破強調了公司通過創新解決方案促進皮膚老化根源的科學進步的承諾。
"This patent filing reflects the passion and effort our team has put into developing something we're very proud of and believe will have a real impact," said Maria Robles, President and CEO of Robles BioCeutics. "Glowselle is more than just an anti-aging cream; it represents a new paradigm in regenerative dermatology, and this patent is a crucial step in protecting our innovative approach as we continue to expand our product offerings."
「這一專利申請反映了我們團隊致力於開發的激情和努力，我們爲此感到非常自豪，並相信這將產生真正影響，」Robles BioCeutics總裁兼首席執行官Maria Robles說。 「Glowselle不僅僅是一款抗衰老霜; 它代表了再生皮膚醫學的一個新範式，這個專利是保護我們的創新方法的關鍵一步，因爲我們繼續擴大我們的產品系列。」
Glowselle, the company's flagship product, replicates an injury signal in the lab, activating the body's own stem cells to promote the natural production of essential growth factors and exosomes. This unique process enhances skin health and beauty from within, setting a new standard for efficacy and safety in the skincare industry.
公司的旗艦產品Glowselle在實驗室中複製了一種傷害信號，激活身體自身幹細胞促進必要生長因子和外泌體的自然產生。 這一獨特過程從內而外增強皮膚健康和美麗，爲護膚行業的功效和安全設立了新標準。
Robles BioCeutics plans to leverage this patent to further its research and development efforts, bringing new and innovative products to the market that cater to the diverse needs of women seeking to maintain their skin's health and natural beauty.
Robles BioCeutics計劃利用這項專利進一步推動其研發工作，推出迎合尋求保持皮膚健康及自然美的女性多樣需求的新穎產品。
About Robles BioCeutics
關於羅布萊斯生物製藥公司
Robles BioCeutics is a regenerative dermatology company dedicated to developing science-driven, effective solutions for skin health and beauty. Founded by Maria Robles, the company's mission is to harness the power of advanced biotechnology to create products that support the skin's natural regenerative processes. With a focus on innovation and efficacy, Robles BioCeutics aims to empower women to maintain their health and beauty through cutting-edge, science-based skincare solutions.
羅布萊斯生物製藥是一家專注於開發科學驅動、有效解決皮膚健康和美麗問題的再生皮膚科公司。由瑪麗亞·羅布萊斯創立，該公司的使命是利用先進的生物技術力量，創造支持皮膚自然再生過程的產品。羅布萊斯生物製藥專注於創新和功效，旨在通過前沿的、基於科學的護膚解決方案幫助女性保持健康和美麗。
For more information, please visit .
有關更多信息，請訪問 .
Company Contact
公司聯繫 Marcia Novero Innodata Inc. Mnovero@innodata.com (201) 371-8015
Maria Robles
President & CEO
Robles BioCeutics
858-609-0948
瑪麗亞·羅布萊斯
總裁兼首席執行官
羅布萊斯生物製藥
858-609-0948
Follow us on Facebook
X: @RBioceutics
在Facebook上關注我們
X: @RBioceutics
SOURCE Robles BioCeutics
來源：Robles BioCeutics
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。